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ABSTRACT
Objective To identify the relative importance of
factors influencing hospital use at the end of life.
Design Retrospective cohort study of person
and health system effects on hospital use in the
past 12 months modelling differences in
admissions, bed days and whether a person died
in hospital.
Setting Residents in England for the period
2009/2010 to 2011/2012 using Hospital
Episodes Statistics (HES) data from all acute care
hospitals in England funded by the National
Health Service (NHS).
Participants 1 223 859 people registered with a
GP in England who died (decedents) in England
(April 2009–March 2012) with a record of NHS
hospital care.
Main outcome measures Hospital admissions,
and hospital bed days and place of death (in or
out of hospital) in the past 12 months of life.
Results The mean number of admissions in the
past 12 months of life averaged 2.28 occupying
30.05 bed days—excluding 9.8% of patients
with no hospital history. A total of 50.8% of
people died in hospital. Difference in hospital
use was associated with a range of patient
descriptors (age, gender and ethnicity). The
variables with the greatest ‘explanatory power’
were those that described the diagnoses and
causes of death. So, for example, 65% of the
variability in the model of hospital admissions
was explained by diagnoses. Only moderate
levels of variation were explained by the hospital
provider variables for admissions and deaths in
hospital, though the impacts on total bed days
was large.
Conclusions Comparative analyses of hospital
utilisation should standardise for a range of
patient specific variables. Though the models
indicated some degree of variability associated
with individual providers, the scale of this was
not great for admissions and death in hospital
but the variability associated with length of stay
differences suggests that attempts to optimise
hospital use should look at differences in lengths
of stay and bed use. This study adds important
new information about variability in admissions
by diagnostic group, and variability in bed days
by diagnostic group and eventual cause of
death.
INTRODUCTION
Care for people at the end of their lives
is receiving increasing attention among
patients, care providers and policy-
makers. End of life care can require diffi-
cult choices between care options, having
to balance the possibility of a marginal
benefit of treatment against the impact
this may have on the quality of life for
the patient and for family care givers.1–3
The last few months of life can often
involve multiple hospital admissions,
extended stays, and numerous consulta-
tions and referrals. This activity can be
very significant in terms of its costs and
has been estimated to account for as
much as 10–12% of total health costs.4 5
In the USA, wide variation in cost of care
at the end of life has been documented,
with aggressive use of hospital care,
intensive care bed days and multiple spe-
cialty referrals contributing to higher
costs in many geographic areas and hos-
pital care settings.6 7 As policymakers
struggle to respond to rising healthcare
costs, greater reliance on potentially less
costly hospital alternatives such as
hospice or home care is clearly an
option.8
In England just under half a million
people die each year (446 779 in 2012),
with two-thirds of those dying aged
75 years or above (68.1% in 2012).9
Most deaths followed a period of chronic
illness (eg, heart disease, stroke, cancer
and dementia) and between 2008 and
2010 55% of deaths occurred in hospital,
with 20% at home and 18% in a care
home.10 In 2008 the Department of
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Health set out a clear strategy for improving care at
the end of life, making a series of recommendations
for example, to improve care planning, coordination
of care, rapid access to care in all settings, training the
workforce and supporting carers.11 The strategy also
pointed to the crucial role of measurement and
research to help monitor progress.12 A number of
initiatives national and local have sought to promote
better access to alternatives to hospital care at the end
of life13 including National Institute for Health and
Care excellence (NICE) quality standards.14
As part of the policy drive to enable more people to
die in the place of their choosing, there is a wide-
spread use of area-based measures to monitor
change.10 There is, however, relatively little analysis
of the factors that might influence end-of-life hospital
use related to the characteristics of the patients or to
those of local health systems. Differences in hospital
use could potentially be due to:
1. The age/gender and socioeconomic status of patients
2. The health problems presented by the patient, and the
cause of death
3. Features of the local health systems including common
practices within individual hospital or primary care pro-
viders, and availability of alternatives to hospital care
These factors vary in the extent to which they are
amenable to change and it is not known which are the
most important in determining observed patterns of
where people die and overall hospital activity at the
end of life. Ideally, comparative indicators should seek
to standardise as far as possible, for factors beyond
the control of the organisation under scrutiny. For
health policymakers there is a particular interest in
identifying how important are those factors relating to
the local provision of care services.
To help inform policymakers and practitioners on
these issues, we examined patterns of hospital use in
the past 12 months of life, and documented the rela-
tive impacts of these three sets of factors. We wanted
to test which factors were significant predictors of
hospital use and place of death.
METHODS
The study analysed a cohort of people in England
who died during the 3 years from 1 April 2009 to 31
March 2012. Cases were identified using a mortality
data set from the Office for National Statistics. This
data set included an anonymised identifier linkable to
English Hospital Episodes Statistics (HES) data, as
well as information on gender, and the place, cause
and date of death. These data were linked to inpatient
HES records from 1 April 2007 to 31 March 2012,
so that we were able to reference at least 2 years of
inpatient data for every person who died. The
inpatient data provided information on the age, place
of residence, ethnic group and registered GP practice
for the individuals who had died. All data extracts
were supplied by the Health and Social Care
Information Centre.15 Permission to use mortality
data was granted by the Office of National Statistics
(ONS) under their Approved Researcher scheme.16
Records were excluded where data were incomplete
or anomalous (eg, admitted to hospital after date of
death). Patients with any period of residence (accord-
ing to their inpatient record) in Wales during the study
were excluded because hospitalisation in Wales’ hospi-
tals is not included in the HES data set. Children aged
1 or under were excluded because end-of-life care at
this age was considered to be very different in terms of
end of life care. We also excluded people with no hos-
pital records in their final year because no information
was available on age, area of residence or ethnicity.
These data sets were used to develop a series of
models to look at three dependent variables: number
of admissions in the past 365 days of life, total
number of bed days in the same period and death in
hospital. The models were built using data sets con-
structed at person level, and used ordinary least
squares regression techniques.
In calculating inpatient bed days, zero lengths of
stay were converted to a 1 day length of stay. For
inpatient stays spanning the end of the year look back
period (ie, where the admission date was more than
365 days prior to death, but the discharge date was
within the 365-day period), only days during the look
back period were included. In these circumstances the
inpatient stay was included in counting admissions.
Death in hospital was determined using the discharge
method recorded on the person’s final inpatient
admission stay and so excluded patients who died
during the process of admission.
A range of variables were created at person level to
test as independent predictors of resource use. These
covered three broad areas: (1) demographic and
patient characteristics (2) clinical conditions and
health problems and (3) measures of health/care ser-
vices supply. These independent variables are
described in more detail below.
Patient characteristics
Age and gender
Derived from individual inpatient hospital records.
For some analyses age was collapsed into five age
bands (2–17, 18–64, 65–74, 75–84 and 85+).
Patient ethnic group
Since 2003/2004 inpatient HES episodes have
recorded ethnicity using the 16 ethnic groupings
employed in the England and Wales sections of the
2001 UK Census. We collapsed these into nine group-
ings and had an additional category for patients with
missing or invalid codes. A patient’s ethnic group is
recorded on each individual record, and for individuals
with conflicting ethnicities reported across multiple
records (or missing/invalid codes in some records, but
valid codes on other records), we assigned the patient
Research
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to a single group in accordance with a hierarchy
described in online supplementary appendix A.
Deprivation measures
We were not able to assess deprivation at the level of
individual patient so we attached a measure for the
local area of residence. Information from the Index of
Multiple Deprivation 2010 contained summary
deprivation indicators for the more than 30 000
‘lower super output areas’ (LSOA) in England.
Information was reweighted for six domains of the
Index of Multiple Deprivation excluding the health
and disability domain. This was carried out using
information published by Communities and Local
Government (CLG).17
Population density
To identify residents in either an urban or rural
setting, we constructed a measure of population
density by weighting population of each LSOA in
England with respect to all other LSOAs using an
inverse square law in a modified gravity model.18 This
was based on 2010 estimates of population from the
Office for National Statistics.19
Clinical conditions/health problems
Diagnostic group
To capture information on a person’s underlying
health condition we created a variable for the most
frequent primary inpatient diagnosis in the last year of
life. Diagnoses were grouped into 147 categories
based on three-character International Classification
of Diseases, Revision 10 (ICD10) code subchapters as
used in reporting by Health and Social Care
Information Centre (HSCIC).20 Those without a diag-
nosis were also grouped together, making 148 diagno-
sis categories in total.
Cause of death
A variable for the underlying cause of death was based
on the ICD10 code for cause of death provided by
the ONS data. Causes of death were grouped into cat-
egories based on the three-character ICD10 code sub-
chapters used by HSCIC.20
Long term conditions
Long-term conditions markers were used as a measure
of underlying morbidity. People were assigned to each
of the long-term condition groupsi where a relevant
ICD10 code was recorded on any inpatient episode in
the penultimate year before death. Each specific long-
term condition was used as an independent variable,
in addition to the total number of different long-term
conditions.
Charlson Index
The Charlson Index weights comorbid conditions to
measure burden of disease21 and is based on the pres-
ence of 17 comorbidities. Scores were calculated from
ICD10 codes and weighted according to the relative
risk of 1 year mortality.21
Health and care services measures
GP characteristics
Information on GP practice characteristics (the
number of whole time equivalent GPs and the total
registered population for 2010) was obtained from
the Health and Social Care Information Centre which
undertakes a census of general practices each year22
(General and Personal Medical Services statistics).
Nursing/care home bed supply
Information on number of nursing and residential
care beds was derived from summary data sets sup-
plied by the Care Quality Commission (CQC). These
identified the location, size and type of all care homes
and hospices registered with CQC in June 2013 at the
local authority level. We constructed a measure of the
density of residential beds per person (at LSOA level)
using a modified gravity model.
Predominant hospitals
People were assigned to a predominant hospital based
on the hospital where the patient had the most admis-
sions in the year before death. For patients where two
or more hospitals had equal most admissions, assign-
ment was based on most frequent day case and out-
patient use. Where no hospital was predominant
based on admissions, day cases, and outpatient use,
the patient was assigned to the hospital with the most
recent admission.
RESULTS
There were in total 1 385 103 records for people who
died between 1 April 2009 and 31 March 2012.
161 244 (11.6%) of these records were excluded from
analysis because of poor data (table 1). The largest
Table 1 Exclusions from study cohort
Number
excluded
Percentage
of excluded
(of all deaths)
Number
remaining
in cohort
All death records 2009/
2010 to 2012/2013
– – 1 385 103
No hospital record in final
year
132 588 9.57% 1 252 515
No gender information 8707 0.63% 1 243 808
No residential (LSOA)
information
774 0.06% 1 243 034
Resided outside England 8008 0.58% 1 242 687
Subsequent (post death
date) hospital activity
11 167 0.81% 1 223 859
Final study cohort – – 1 223 859
LSOA, lower super output areas.
iLong terms groups limited to: sickle cell anaemia, diabetes,
hypertension, congestive heart failure, chronic obstructive
pulmonary disease, ischaemic heart disease, asthma, connective
tissue disease/rheumatoid arthritis, renal diseases, cardiovascular
disease, angina.
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group of exclusions (9.57%) was for those people
with no record of any hospital activity in the final
year of life which had to be excluded as we had no
information about them to use in our models. This
left a cohort of 1 223 859 individuals.
Almost two-thirds of the final study cohort were
over 75 years old, 51% were female and 89% had
their ethnicity recorded as white (see table 2). No
member of the study cohort was missing age informa-
tion and less than a tenth of people had missing ethni-
city, these people were categorised as having
‘unknown’ ethnicity and were included in subsequent
analysis.
Overall the cohort had an average of 2.28 hospital
admissions, accounting for 30.1 bed days in the final
year of life (see table 3). A total of 51.3% died in hos-
pital. If the 9.6% of people with no hospital history
were included the average values in the past
12 months of life were 2.1 admissions, 27.1 bed days
and with 4.63% dying in hospital.
Figure 1 summarises trends in hospital admission
(in this case based on dates of discharge) for specific
age bands over the final 12 months of life. This
demonstrates the sharp increase in hospital activity
over the past 3 months of life. These past 3 months
accounted for 57.0% of total admissions in the final
year.
There were major differences in patterns of hospital
use in the past 12 months of life according to the age
of the patient at death (see figure 2). Younger patients
had higher admission rates in the last year of life, but
shorter stays in hospital and were less likely to die in
hospital.
Table 3 summarises the performance of the three
regression models in explaining variability and shows
the average admissions and bed days, and the propor-
tion who died in hospital. Each of the models we con-
structed showed some explanatory power as indicated
by the reduction in variability in the outcome variable,
as evidenced by the decrease Root Mean Square Error
(RMSE) and coefficient of variance (CV). There was
greatest variability in the models for bed days before or
after adjustment. Indeed, the adjusted bed days model
only decreased the CV by 0.082 (compared to 0.118
for deaths in hospital), and it had the lowest r2. The
best performing model in terms of explanatory power
was the one that aimed to predict death in hospital
which was able to explain 21.9% of the variability.
Within each model the individual coefficients were
significant for the majority of variables (details in
online supplementary appendix B). Table 4 sum-
marises the explanatory power of various groups of
variables in terms of the reduction in variance asso-
ciated with each variable group—this effectively com-
pares the variance with and without that set of
variables in the model. The impacts of these variable
groups varied between the different models. For
example, age was an important explanatory variable
in relation to the numbers of admissions, accounting
for 11.1% of explained variation, though much less
important when looking at whether a person died in
hospital (0.7%) or total bed days (0.4%).
Ethnicity was also one of the more influential vari-
able groups. There were significant differences in hos-
pital use between ethnic groups that seemed to impact
on levels of admission and bed days—but less so when
looking at whether a person died in hospital. Some
non-Caucasian groups had higher admission rates in
the last year of life, more bed days, and were more
likely to die in hospital. When compared to the
white groups, non-Caucasian ethnic groups had
higher levels of admissions (8% higher) and bed days
(9% higher), with less variance in the percentage
Table 2 Key characteristics of the cohort
Category Number Per cent
Age
2–17 3604 0.29
18–64 209 045 17.08
65–74 218 987 17.89
75–84 399 909 32.68
85+ 392 314 32.06
Gender
Male 597 931 48.86
Female 625 928 51.14
Ethnicity
Asian other/mixed 4089 0.33
Black African 3458 0.28
Black Caribbean 7471 0.61
Bangladeshi 1554 0.13
Black other/mixed 3088 0.25
Indian 10 358 0.85
Other ethnic group/mixed 10 197 0.83
Pakistani 5389 0.44
White 1 087 576 88.86
Unknown 90 679 7.41
Table 3 Summary statistics for model performance
Model dependent variable:
Admissions
Bed
days
Died in
hospital
Mean 2.28 30.05 51.3%
SD 2.17 38.91 50.0%
10 centile 0.00 0.00 0.0%
Median 2.00 17.00 100.0%
90 centile 5.00 75.00 100.0%
Unadjusted coefficient of variation 0.949 1.295 0.975
Unadjusted root mean square error 2.17 38.91 50.0
Model performance
R2 0.187 0.123 0.219
Adjusted coefficient of Variance 0.856 1.213 0.862
Adjusted root mean square error 1.95 36.45 44.2
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dying in hospital (4% higher). There were also differ-
ences between the non-Caucasian ethnic subgroups.
We did see some association with the deprivation
scores for the lower super output area where the
person lived and greater levels of hospital activity but
the effects were not strong once other factors were
taken into account.
The largest explanatory power in all three models was
linked with the set of diagnostic groupings which col-
lectively explained 65% of the variation in admission
and just over half the variation in bed days and deaths in
hospital. The individual coefficients for almost all diag-
nostic groups were positive and significant indicating
that the presence of diagnoses in the year before admis-
sion was associated with more hospital use. The cause
of death was less powerful as an explanation of differ-
ences in hospital admission and bed days, but was more
strongly linked with patients dying in hospital.
In contrast the Charlson Comorbidity Index and
the count of long terms conditions were positively
associated with higher hospital activity and costs but
had much less impact than the diagnostic groups.
The impacts of factors in the local health systems
seemed to be relatively modest, except in the case of a
person’s predominant hospital in the last year of life.
The GP variables did not seem to be influencing hos-
pital use to any greater extent. The number of care
home and hospice beds in the local area was nega-
tively associated with hospital activity—areas with
more care home and hospice places tended to have
fewer hospital admissions. Though the variable itself
was statistically significant it did not seem to explain a
high level of variability on the data compared to other
factors. The total variability linked with the provider
hospital variables collectively was around 8% for
admissions, and nearly 29% for bed days. However,
in the vast majority of cases individual provider
effects were not statistically significant.
DISCUSSION
Hospital use at the end of life is important in terms of
the overall quality of healthcare delivery. This analysis
of a large cohort of people who died has helped to
outline some of the key factors influencing resource
use at this critical part of the care pathway.
Financial pressures on health systems will inevitably
lead to closer examination of the appropriateness of
where people are treated. This tendency has become
especially significant in discussions over end of life
care. Our analysis demonstrates for a very large group
of decedents that hospital use in the past 12 months
of life is significant in terms of resource use, with an
average of 2.3 admissions and 30 bed days for every
person that died. Our cohort did exclude 9.6% of
cases with no hospital records, but even if these had
been included in the denominators the average
Figure 1 Admissions per 10 000 people, per month prior to death (note log scale).
Figure 2 Average number of admissions and bed days in the
last 365 days of life and proportion dying in hospital by age at
death (expressed relative to cohort mean).
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resource use would still have been substantial. We also
noted how hospital use is especially marked in the
past few weeks of life with 57% of all admissions
being in the past 3 months.
Our analysis highlights the significance of the role
of clinical case types in understanding variations, with
existing health problems and the ultimate cause
of death being particularly important in explaining
differences in levels of care at the end of life.
Differences in patterns of hospital use by age under-
score the importance of adjusting rates for age when
examining variations in relation to other variables
such as ethnicity, predominant hospital or geographic
area. There could be a number of reasons why differ-
ences by age persist even after adjustment for other
variables. For example, younger patients are likely to
have greater availability of support for care outside
the hospital resulting in shorter stays. Some factors
are more difficult to explain—differences linked with
ethnicity for example may be an indication that some
cultural and religious factors may influence utilisation.
Other studies have observed differences in access to
palliative care by ethnic group.23 The residual differ-
ences among ethnic subgroups are described in more
detail in an accompanying study.
Though it is often assumed that the individual pro-
vider hospital may be an important factor in explain-
ing differential patterns of hospital use at the end of
life—we found that the impacts were relatively small.
Of our three models the one explaining bed days use
was most affected by the hospital provider variables,
suggesting that that the effects at the individual hos-
pital level on admissions and death in hospital are less
significant than in total bed days. An implication of
this is that hospitals seeking to improve care of the
elderly near the end of their lives might be advised to
focus on ensuring appropriate stay lengths.
Limitations
This study had some important limitations, the first
being that the analyses looked only at resource use
and did not compare the experiences of patients or
carers. There were other variables that are potentially
important predictors that we could not include—for
example, living arrangements and strength of family/
carer support. Our categorisation of diagnostic group
makes assumptions about the accuracy of and consist-
ency of coding which in some cases may be imperfect.
Similarly we were unable to capture information
about the level of community-based services for end
of life care. Our analyses exclude a minority of people
who had no prior recorded hospital use—though we
suspect that differential findings in this group would
not be sufficiently large to alter our conclusions.
The analysis of the models’ explanatory power also
leads us to note that there was a significant amount of
variation between patients that we could not explain.
Overall r2 of the order of 0.2 is fairly typical perform-
ance for models on this scale and for models that seek
to explain differences in resource use or future hos-
pital admission24 25—an indication of how use of
health services does include high levels of uncertainty.
Implications
This analysis highlights that hospital utilisation at the
end of life is significant and that comparative analyses
Table 4 Explanatory power of different sets of variables on admission in the last year of life, bed days and deaths in hospital
Admissions Bed days Died in hospital
Variable group D.F. Mean square F value
Percentage of
‘explained’ F value
Percentage of
‘explained’ F value
Percentage of
‘explained’
Patient characteristics
Age bands 4 12 586.7 3295.2 11.1 106.04 0.4 428.21 0.7
Sex 1 1687.5 441.8 0.4 15.79 0.0 181.82 0.1
Ethnicity 9 2251.7 589.5 4.5 372.13 3.4 42.64 0.2
IMD (excluding health) 1 536.4 140.4 0.1 213.99 0.2 193.82 0.1
Population density 1 87.3 22.9 0.0 219.84 0.2 179.1 0.1
Clinical/health characteristics
Diagnostic group 144 2055.3 538.1 65.0 356.65 52.6 970.73 57.0
Cause of death 116 369.8 96.8 9.4 112.10 13.3 753.39 35.7
Number of long-term conditions 9 202.1 52.9 0.4 10.90 0.1 17.88 0.1
Charlson Index 21 162.1 42.4 0.7 34.31 0.7 256.72 2.2
Local health system
List size GP 1 3.6 1.0 0.0 3.65 0.0 3.44 0.0
Number of GP FTE 1 27.5 7.2 0.0 9.39 0.0 12.63 0.0
Access to care home/hospice beds 1 79.1 20.7 0.0 52.28 0.1 103.17 0.0
Predominant hospital 364 104.6 27.4 8.4 77.34 28.8 26.48 3.9
Note all variables sig in all models at p<0.001 except GP list size where p>0.01 in all models.
D.F., Degrees of Freedom; FTE, Full Time Equivalent; GP, General Practitioner; IMD, Index of Multiple Deprivation.
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need to take account of factors that are beyond the
control of local health systems—for example, dece-
dents’ prior health status and ultimate cause of death.
The models we developed can be used to adjust for
these variables when estimating expected levels of
resource use for making comparisons of specific orga-
nisations or areas. However, we do note that though
we did detect differences associated with provider
hospitals these were greatest for bed day use, and less
important in relation to total admissions or whether a
person died in hospital.
Hospital-specific differences raise important con-
cerns that patient preferences about risk/benefits,
aggressiveness of treatment and the course of care in
some cases may not be taken fully into account (with
provider practice style having undue influence on care
decisions). They also suggest that cost savings might
be feasible if high-rate areas can adopt more conserva-
tive utilisation patterns. This analysis suggests that
variability in bed day utilisation may be more tractable
than differences in admissions or even deaths in hos-
pital. However, designing particular intervention strat-
egies will require further analysis to determine the
extent to which greater hospital use is attributable to
either a lack of alternatives to hospital care, or to
differences in local clinical practice style. If the latter
then we may need to consider how patient/family pre-
ferences about the course of care are more effectively
incorporated into the treatment decision-making
process.
The extent of variation in hospital use at the end of
life in England that we have documented is relatively
modest, at least compared to the USA experience.26
However, these findings raise important issues for pol-
icymakers, and suggest the need for further study to
determine whether action is required to ensure that
the care received by patients is concordant with
patient and family preferences about benefits, risks,
and setting of care.
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